ctype
lectin
receptor
recogn
glycan
divers
rang
pathogen
includ
parasit
interact
dcsign
pathogen
trigger
specif
signal
event
modul
dcmatur
activ
regul
tcell
activ
dc
work
evalu
whether
f
hepatica
glycan
immun
modul
dc
via
dcsign
demonstr
dcsign
interact
f
hepatica
glycoconjug
mannos
fucos
residu
also
show
mannos
present
highmannos
structur
hybrid
trimannosyl
nglycan
termin
glcnac
furthermor
demonstr
f
hepatica
glycan
induc
dcsign
trigger
lead
strong
product
tlrinduc
addit
parasit
glycan
induc
regulatori
dc
via
dcsign
decreas
allogen
cell
prolifer
via
induct
anergicregulatori
cell
highlight
role
dcsign
regul
innat
adapt
immun
respons
f
hepatica
data
confirm
immunomodulatori
properti
dcsign
trigger
pathogenderiv
glycan
contribut
identif
immunomodulatori
glyan
helminth
might
eventu
use
design
vaccin
fasciolosi
ctype
lectin
receptor
clr
dendrit
cell
dc
recogn
broad
rang
pathogen
interact
specif
carbohydr
signatur
expressproduc
also
regul
signal
cellular
interact
dc
migrat
cell
bind
modul
innat
adapt
immun
differ
clr
identifi
critic
player
carbohydratemedi
immuneregul
induc
pathogen
mr
mgl
dectin
dcsign
latter
also
known
grab
nonintegrin
type
ii
transmembran
protein
bind
mannoseor
fucosecontain
nglycan
previou
work
demonstr
dcsign
interact
glycan
structur
varieti
pathogen
rang
viru
fungi
fact
dcsign
bind
glycoconjug
hiv
coronaviru
herp
simplex
viru
helicobact
pylori
mycobacterium
tuberculosi
candida
albican
well
cancerrel
glycan
recent
differ
paper
report
dcsign
also
interact
glycan
form
parasit
therebi
modul
immun
respons
inde
dcsign
recogn
protozoan
parasit
leishmania
sp
also
helminth
parasit
schistosoma
mansoni
trichuri
sui
dcsign
abundantli
express
varieti
dc
includ
monocyteand
deriv
dc
well
vivo
dermal
dc
skin
immatur
dc
peripher
lymphoid
tissu
interact
dcsign
pathogen
trigger
specif
signal
event
modul
dc
activ
variou
level
influenc
phagocytosi
suppress
tlrinduc
matur
dc
intern
pathogenderiv
molecul
modifi
dcadhes
migrat
antigen
present
regul
tcell
activ
dc
addit
dcsign
also
involv
induct
antiinflammatori
signal
result
induct
anerg
cell
interestingli
recent
report
extract
mansoni
egg
f
hepatica
worm
trigger
dcsign
specif
signal
pathway
dc
direct
differenti
cell
follicular
helper
cell
allow
long
surviv
host
helminth
parasit
evad
host
immun
alter
dc
matur
function
result
polar
fasciolosi
helminth
infect
caus
fasciola
hepatica
paramount
import
due
wide
spectrum
definit
host
worldwid
distribut
affect
cattl
human
health
sever
studi
independ
demonstr
f
hepaticaderiv
molecul
inhibit
decreas
dc
activ
result
induct
tolerogen
phenotyp
addit
f
hepatica
tegument
antigen
modul
dc
activ
suppress
mapksign
upregul
express
suppressor
cytokin
signal
furthermor
demonstr
dc
mice
infect
f
hepatica
semimatur
phenotyp
character
low
mhc
ii
express
high
secret
immunoregulatori
cytokin
thu
hypothes
f
hepatica
may
modul
dc
function
fate
mean
control
pathogenesi
surviv
infect
host
recent
report
includ
brought
insight
role
f
hepatica
glycan
mediat
regul
dcmatur
clr
recognit
group
recent
describ
glycan
structur
produc
f
hepatica
particip
modul
bone
marrowderiv
dc
bmdc
inducemedi
product
infect
moreov
mannos
inhibit
indic
mannosespecif
receptor
mediat
recognit
f
hepatica
glycan
dc
recent
mannos
receptor
found
mediat
parasit
tegument
glycan
recognit
bmdc
although
experi
suggest
also
mannosespecif
clr
particip
f
hepatica
modul
dc
last
mrdepend
mechan
induc
cell
anergi
dc
load
parasit
tegument
molecul
report
yet
molecular
mechan
associ
modul
human
dc
function
f
hepatica
scarc
thu
sought
evalu
whether
f
hepatica
glycoconjug
interact
dcsign
whether
interact
regul
stimulatori
function
dc
evalu
capac
induc
regulatori
anerg
cell
work
show
f
hepatica
glycan
human
dc
induc
strong
product
tlrinduc
process
requir
interact
dcsign
sinc
dcsign
shown
bind
man
fuc
glycan
recogn
dcsign
fhte
highli
suggest
mediat
dcsign
effect
addit
glycan
induc
regulatori
monocytederiv
dc
modc
via
dcsign
decreas
allogen
cell
prolifer
highlight
role
dcsign
regul
innat
adapt
immun
respons
f
hepatica
data
confirm
immunomodulatori
properti
dcsign
trigger
f
hepaticaderiv
glycoconjug
contribut
deep
understand
immunoregul
strategi
helminth
dcsign
uptak
f
hepatica
glycoconjug
mediat
enhanc
product
tlrinduc
modc
determin
whether
f
hepatica
glycan
modul
dcmediat
immun
respons
first
evalu
whether
total
prepar
parasit
compon
fhte
modul
product
cytokin
induc
matur
stimulu
dc
end
immatur
modc
cultur
presenc
absenc
lp
fhte
product
differ
cytokin
evalu
cultur
medium
although
fhte
alon
induc
express
cytokin
modc
cultur
togeth
matur
stimulu
enhanc
product
modc
fig
b
interestingli
enhanc
product
abrog
fhte
glycan
oxid
metaperiod
fhmpox
common
method
use
evalu
biolog
activ
glycan
fig
result
indic
f
hepatica
glycoconjug
mediat
enhanc
product
tlrinduc
modc
next
investig
whether
parasit
compon
taken
modc
end
studi
intracellular
rout
fhte
compon
imag
flow
cytometri
shown
fig
local
labeledfht
molecul
intracellular
coloc
minuteincub
period
earli
endosom
antigen
lysosom
marker
uptak
labeledfht
modc
also
confirm
flow
cytometri
inhibit
upon
incub
egta
fig
suggest
particip
clr
process
furthermor
fhteuptak
modc
inhibit
mrand
dcsignspecif
antibodi
modifi
use
antidcir
antimgl
antibodi
fig
final
evalu
capac
mr
dcsign
recogn
coatedfht
use
mrand
dcsignfc
construct
confirm
particip
recognit
glycan
present
fhte
inhibit
chelat
agent
egta
fig
given
capac
mr
dcsign
recogn
intern
fhte
investig
whether
receptor
mediat
enhanc
product
tlrinduc
modc
stimul
fhte
modc
incub
fhte
lp
presenc
mr
dcsign
dcirand
mglspecif
block
antibodi
shown
fig
antidcsign
antibodi
capabl
restor
level
scientif
report
doi
produc
lpsstimul
modc
addit
dcsign
block
antibodi
also
restor
level
fig
suggest
dcsign
mr
mediat
modul
trigger
fhte
togeth
tlr
ligand
show
particip
recognit
f
hepatica
glycan
regul
tlrinduc
product
dc
analyz
detail
interact
dcsign
fhte
imag
flow
cytometri
result
fig
demonstr
labeledfht
interact
dcsign
cell
surfac
fig
time
coloc
dcsign
also
earli
timepoint
fig
b
interestingli
minut
incub
coloc
fhte
dcsign
observ
shown
white
arrow
fig
data
suggest
dcsignmedi
fhteuptak
modc
could
lead
deliveri
parasit
glycoconjug
earli
endosom
order
character
natur
carbohydr
recogn
dcsign
carri
two
differ
approach
bind
inhibit
carbohydr
treatment
exoglycosidas
interact
dcsignfc
coatedfht
inhibit
incub
egta
mannan
dcsignspecif
block
antibodi
inhibit
detect
galnac
isotyp
antibodi
control
fig
consid
dcsign
recogn
mannosyl
fucosyl
glycan
evalu
bind
fhte
treat
mannosidas
fucosidas
enzym
treatment
fhte
glycosidas
inhibit
dcsign
bind
inhibit
treatment
fhte
fucosidas
mannosidas
result
inhibit
rate
fig
indic
dcsign
interact
fucosyl
mannosyl
parasit
glycan
galnacas
treatment
fhte
use
control
reveal
chang
dcsign
bind
fhte
expect
due
lack
mgl
bind
observ
fig
character
nglycan
bind
specif
dcsign
reveal
dcsign
may
recogn
complextyp
nlink
glycan
express
moieti
lesser
extent
oligomannosetyp
nglycan
determin
mannosyl
fucosyl
nglycan
moiet
present
fhte
may
act
dcsign
ligand
character
quantifi
parasit
nglycan
glycan
nanoprofil
analys
show
nglycan
present
fhte
contain
mainli
high
mannos
structur
hybrid
complex
glycan
termin
glcnac
supplementari
fig
mannosyl
structur
constitut
potenti
ligand
dcsign
paucimannos
glycan
also
detect
howev
sinc
fucosyl
identifi
common
core
structur
unit
supplementari
fig
structur
would
repres
potenti
ligand
dcsign
recogn
glycan
termin
fucosyl
ldnf
le
x
pseudol
investig
whether
immun
modul
induc
fhte
lpsmatur
modc
affect
tcell
stimulatori
function
incub
fhtetreat
modc
presenc
absenc
lp
allogen
cell
cell
prolifer
product
significantli
reduc
lpsstimul
modc
incub
presenc
fhte
fig
moreov
product
partial
restor
use
antidcsign
block
antibodi
suggest
fhte
regul
stimulatori
capac
modc
process
mediat
least
part
dcsign
fig
f
hepatica
mannoserich
glycan
next
investig
effect
fhte
exposur
dc
cell
prolifer
secondari
mlr
cell
expos
dc
puls
fhte
show
decreas
capac
prolifer
respons
second
stimul
fulli
activ
dc
fig
interpret
induct
anerg
cell
reg
cell
primari
mlr
interestingli
induct
anerg
regulatori
cell
fhtestimul
modc
mediat
dcsign
sinc
incub
dcsignspecif
block
antibodi
restor
cell
prolifer
fig
find
illustr
mannos
glycan
fhte
interact
dcsign
dc
induc
toler
inflammatori
condit
induct
cell
suppressor
capac
studi
provid
evid
f
hepatica
glycan
modul
human
dc
dcsign
favor
induct
treg
cell
anergi
particular
show
oligomannos
glycan
present
fhte
prepar
enhanc
tlrinduc
product
although
f
hepatica
glycoconjug
recogn
intern
mr
dcsign
dc
observ
immunomodul
tlrmatur
dc
mediat
dcsign
mr
dcir
mgl
suggest
main
role
receptor
dcimmunoregulatori
properti
induc
helminth
dcsign
interact
wide
rang
pathogen
major
impact
public
health
includ
virus
bacteria
parasit
via
fucos
instanc
lewi
sulfolewi
structur
highmannos
glycan
cadepend
manner
howev
dcsign
interact
helminth
report
via
fucosyl
glycan
highmannos
structur
oligomannos
paucimannos
nglycan
present
fhte
could
constitut
ligand
dcsign
mannos
result
demonstr
capac
dcsign
recogn
mannosyl
glycoconjug
f
hepatica
compon
sinc
bind
dcsign
fhte
partial
abolish
mannosidas
treatment
addit
also
confirm
dc
interact
helminth
fucosylatedglycan
via
dcsign
consid
identifi
potenti
fucosyl
nglycan
could
serv
ligand
dcsign
togeth
fact
defucosyl
fhte
reduc
dcsign
recognit
parasit
compon
propos
dcsign
fucosyl
ligand
present
oglycan
glycolipid
note
sinc
fhte
total
parasit
lysat
contain
extern
intern
glycoconjug
thu
establish
role
dcsign
f
hepatica
infect
vivo
studi
necessari
f
hepatica
evad
host
immun
differ
mechan
includ
immunomodul
dc
matur
function
result
alter
polar
induc
tolerogenicregulatori
properti
previous
report
express
semimatur
dc
f
hepatica
infect
anim
indic
parasit
abl
immuneregul
dc
infect
demonstr
f
hepatica
glycan
immunomodul
tlrinduc
matur
human
dc
dcsigndepend
process
thu
dcsign
interact
f
hepatica
glycan
mediat
increas
product
tlrmatur
dc
key
immuneregulatori
cytokin
impair
prolifer
cytokin
product
migratori
capac
effector
cell
induc
cell
anergi
hand
exert
immunostimulatori
suppress
effect
interestingli
induc
product
induc
differenti
type
regulatori
cell
agreement
result
fucoseinduc
trigger
dcsign
result
induct
express
secret
dc
drive
subsequ
follicullar
helper
polar
furthermor
type
phenotyp
dc
induc
helminth
mansoni
suggest
fucosyl
glycan
present
fhte
would
trigger
dcsignsign
addit
result
indic
dcsign
recogn
next
fucosyl
glycan
also
mannosyl
glycan
present
parasit
may
differ
function
consequ
increas
reg
addit
experi
need
determin
whether
glycan
moieti
f
hepatica
glycan
trigger
differ
dcsign
signal
pathway
clrtrigger
correl
regulatori
cell
differenti
differ
patholog
context
particular
dcsign
favor
follicular
helper
regulatori
cell
polar
understand
whether
f
hepaticatrigg
dcsign
dc
alter
cell
activ
evalu
whether
tlrmatur
dc
condit
parasit
compon
abl
limit
cell
prolifer
result
indic
human
dcsign
promot
tolerogenicregulatori
state
dc
sinc
f
hepaticacondit
dc
induc
regulatori
modc
via
dcsign
decreas
allogen
cell
prolifer
induct
induct
tcell
toler
hand
interact
myelin
oligodendrocyt
glycprotein
mog
dcsign
context
simultan
activ
result
enhanc
secret
decreas
cell
prolifer
furthermor
h
pylori
glycan
interact
dcsign
induc
tolerogen
dc
fail
induc
cell
effector
function
induc
regulatori
cell
context
f
hepatica
immunoregulatori
properti
clr
also
particip
induct
cell
anergi
recent
propos
mr
bone
marrowderiv
dc
induc
anergiclik
cell
via
dc
although
small
reduct
cell
anergi
found
use
dc
knockout
mice
suggest
clr
particip
process
furthermor
process
seem
mediat
recognit
parasit
glycoconjug
mr
bmdc
mr
interact
cell
thu
work
provid
addit
mechan
induct
cell
anergi
induc
f
hepaticacondit
dc
conclus
work
demonstr
f
hepatica
fucosyl
mannosyl
glycoconjug
recogn
dcsign
turn
trigger
tolerogen
program
tlrmatur
dc
presenc
parasit
glycosyl
molecul
character
increas
product
confer
dc
capac
induc
regulatoryanerg
cell
fig
result
highlight
biolog
role
glycan
immun
evas
mechan
trigger
helminth
ethic
statement
human
monocyt
isol
buffi
coat
healthi
donor
accord
guidelin
regul
ethic
committe
vu
univers
medic
center
amsterdam
netherland
inform
consent
given
donor
use
blood
sampl
adult
worm
collect
routin
work
local
abattoir
carrasco
montevideo
uruguay
protocol
approv
uruguayan
committe
anim
research
honoraria
de
anim
uruguay
ethic
committe
vu
univers
medic
center
amsterdam
netherland
prepar
protein
lysat
f
hepatica
live
adult
worm
f
hepatica
obtain
bile
duct
bovin
liver
wash
phosphat
buffer
salin
pb
ph
mechan
disrupt
sonic
centrifug
g
min
supernat
collect
dialyz
pb
obtain
total
lysat
fhte
quantifi
store
carbohydr
glycol
group
present
fhte
oxid
sodium
period
mm
oxid
perform
room
temperatur
min
dark
follow
reduct
sodium
borohydrid
mm
reactiv
aldehyd
group
scientif
report
doi
result
oxid
lysat
refer
fhmpox
order
perform
control
experi
follow
control
extract
prepar
fhcb
consist
fhte
subject
whole
treatment
except
incub
sodium
period
cmpox
consist
pb
subject
entir
treatment
lysat
dialyz
pb
protein
concentr
measur
use
bicinchonin
acid
assay
sigmaaldrich
st
loui
mo
endotoxin
level
determin
use
limulu
amebocyt
lysat
kit
pyrochrom
associ
cape
cod
protein
prepar
show
low
level
endotoxin
abl
induc
dcmatur
read
modc
incub
control
cmpox
produc
level
cytokin
cultur
supernat
modc
cultur
medium
alon
monocyt
isol
peripher
blood
mononuclear
cell
pbmc
buffi
coat
healthi
donor
sanquin
netherland
lymphoprep
gradient
axisshield
san
diego
ca
subsequ
percol
gradient
centrifug
ge
healthcar
life
scienc
netherland
inform
consent
obtain
blood
donor
use
blook
sampl
dc
gener
cultur
purifi
monocyt
complet
medium
consist
rpmi
thermo
fisher
scientif
netherland
supplement
fetal
bovin
serum
biowhittak
uml
penicillinstreptomycin
lonza
netherland
mm
glutamin
lonza
netherland
combin
uml
biosourc
belgium
gmcsf
uml
biosourc
belgium
day
dcmatur
assay
modc
well
incub
co
plate
platebound
fhte
fhmpox
fhcb
gml
presenc
absenc
gml
appropri
dc
preincub
hr
block
antidcsign
dcir
mr
mgl
antibodi
level
determin
specif
elisa
ebiosci
ca
biosourc
belgium
overnight
incub
altern
determin
quantit
real
time
rtpcr
qrtpcr
stimul
hr
fhtelpsstimul
modc
wash
incub
day
allogen
naiv
cell
previous
purifi
neg
select
invitrogen
prime
cell
recov
wash
allow
rest
presenc
immunotool
primari
stimul
prime
cell
wash
restimul
cocultur
lpsactiv
modc
origin
donor
differ
ratio
realtim
pcr
total
rna
isol
dc
cultur
use
trireag
sigmaaldrich
realtim
pcr
set
use
sybr
green
method
abi
sequenc
detect
system
previous
describ
supplementari
tabl
show
list
primer
use
clrfc
bind
assay
nunc
maxisorb
plate
roskild
denmark
coat
fhte
g
ml
overnight
plate
block
bsa
tsm
mm
tri
ph
mm
nacl
mm
cacl
mm
mgcl
gml
differ
hclrfc
tsm
ad
h
room
temperatur
specif
bind
block
preincub
hclrfc
ca
chelat
egta
mm
hmglfc
specif
bind
block
free
galnac
mm
sigmaaldrich
block
antihmgl
antibodi
gml
preincub
min
bind
detect
use
peroxidaselabel
antihuman
iggfc
antibodi
jackson
immunoresearch
laboratori
pa
bind
visual
tetramethylbenzidin
tmb
substrat
sigma
aldrich
optic
densiti
measur
spectrophotometri
nm
indic
fhte
pretreat
follow
exoglycosidas
nacetylgalactosaminidas
chicken
liver
fucosidas
bovin
kidney
manosidas
jack
bean
prozym
ca
indic
manufactur
instruct
treatment
done
fucosidas
mannosidas
time
buffer
sodium
acet
mm
ph
use
intern
assay
intern
bind
fhte
modc
analyz
flow
cytometri
briefli
modc
well
incub
alexa
fhte
h
complet
medium
assess
uptak
complet
medium
assess
bind
cell
wash
twice
bind
intern
cell
analyz
flow
cytometri
imag
fac
modc
incub
fhte
h
complet
medium
fix
permeabil
stain
dcsign
clone
clone
clone
specif
antibodi
bd
bioscienc
analyz
imag
fac
modc
acquir
imagestreamx
amni
corp
previous
describ
minimum
cell
acquir
per
sampl
flow
rate
rang
cellss
identif
nglycan
present
fhte
perform
previous
describ
briefli
mg
fhte
freez
dri
dissolv
l
buffer
sodium
phosphat
buffer
ph
contain
urea
tiourea
sd
mercaptoetanol
sonic
one
hour
l
buffer
sodium
phosphat
buffer
ph
contain
igep
ad
neutral
inhibitori
effect
sd
pngasef
activ
sonic
anoth
min
final
l
sodium
phosphat
buffer
ph
u
pngase
f
ad
mixtur
incub
least
h
purif
glycan
structur
perform
use
pgc
spe
column
porou
activ
charcoal
remain
deterg
remov
incub
deterg
bead
purifi
scientif
report
doi
nglycan
derivat
amc
via
reduct
amin
reduc
end
briefli
oligosaccharid
mix
mg
amc
mg
reduc
agent
picolin
boran
thoroughli
vortex
mixtur
incub
hour
separ
quantif
character
glycan
perform
use
system
intercal
nanofluoresc
detector
first
dimens
capillari
wax
trap
column
use
trap
charg
oligosaccharid
speci
unbound
neutral
oligosaccharid
trap
onto
trap
column
mm
dionex
netherland
analyz
long
revers
phase
nanolc
column
mm
prepar
inhous
glycan
speci
quantifi
base
fluoresc
structur
identifi
base
inform
obtain
msm
fragment
pattern
subsequ
wax
bound
charg
speci
elut
mm
ammonium
format
trap
onto
trap
column
analyz
mention
statist
analysi
result
analyz
use
oneway
anova
nonparametr
friedman
test
dunn
posttest
twoway
anova
follow
bonferrroni
multipl
comparison
test
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
result
consid
significantli
differ
p
